Nonbacterial thrombotic endocarditis (NBTE) is an uncommon condition that carries significant morbidity and an in-hospital mortality rate of up to 36%. Involvement of a prosthetic valve with NBTE is even more rare. We present a case of prosthetic mitral valve NBTE that manifested 5 months after surgical mitral valve replacement. The patient's presentation was complicated by complex medical comorbidities and previous contraindications to multiple anticoagulant agents that included calciphylaxis secondary to warfarin and high concern for heparin-induced thrombocytopenia. The patient was taking apixaban when she developed prosthetic valve NTBE. The patient was transitioned to fondaparinux, with resolution of the mitral valve vegetations. Warfarin and heparin are first-line anticoagulant agents for antiphospholipid syndrome and NBTE, respectively. There is limited evidence for different anticoagulant agents in NBTE. Our case highlights nuance in the diagnosis of NBTE and complexities of anticoagulation decisions in patients with contraindications to various agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaccas.2024.103091 | DOI Listing |
JACC Case Rep
January 2025
Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:
Background: Although rare, embolization of left atrial appendage occlusion (LAAO) devices carries a significant morbidity and mortality burden.
Case Summary: An asymptomatic 77-year-old woman with inability to tolerate anticoagulation due to gastrointestinal bleeding presented for 45-day transesophageal echocardiography following LAAO with a Watchman device, which demonstrated incidental device migration to the left ventricular outflow tract (LVOT). Percutaneous extraction was performed using a novel technique with rat tooth/alligator forceps to successfully retrieve the Watchman from the LVOT using a transaortic approach.
Catheter Cardiovasc Interv
March 2025
West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) is increasingly applied in patients with high surgical risk. We aimed to evaluate whether the PASCAL system can be applied in an all-comers cohort irrespective of the underlying anatomy and whether technical features influence therapeutic success.
Methods: In this prospective, observational study we enrolled consecutive patients (n = 80) with mitral regurgitation (MR) 3+ and 4+ scheduled for M-TEER.
World J Emerg Surg
March 2025
Department of Trauma Surgery and Orthopedics, Goethe University Frankfurt, University Hospital, 60590, Frankfurt, Germany.
Background: Heart injuries following polytrauma (PT) are identified as a predictor of poor outcome. The diagnostic algorithm of cardiac damage after trauma consists of the systemic measurement of cardiac damage markers, a 3-channel ECG and if there are any suspicious findings, the conduction of a transthoracic echocardiography (TTE). The aim of this study was to implement a systematic analysis of cardiac function using TTE in PT-patients.
View Article and Find Full Text PDFESC Heart Fail
March 2025
Department of Cardiology, Cardiology I, University Medical Center Mainz of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Background: Atrial secondary mitral valve regurgitation (ASMR) is a distinct anatomical subset of secondary mitral regurgitation (SMR). Evidence of the effect of transcatheter edge-to-edge repair (TEER) on left atrial (LA) anatomy and function, especially reverse remodelling (LARR), is still sparse.
Methods And Results: We retrospectively evaluated all consecutive patients treated with TEER for mitral regurgitation (MR) in our centre between January 2013 and October 2023.
J Echocardiogr
March 2025
Cardiology Department, Fethi Sekin City Hospital, Elazığ, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!